Anti-TNF drugs have a relatively good safety profile but are associated with several adverse events, which include the risk of malignancy, demyelinating disorders, lupus-like syndrome, congestive heart failure, and opportunistic infections.4 Patients with severe RA are prone to infections. Here, TNF is linked to rheumatoid arthritis.